Statera Biopharma, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Statera Biopharma, Inc. had Stockholders' Equity Attributable to Noncontrolling Interest of $73.02 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2022-11-14
- 2022-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $73.02K.
- 2022-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $67.44K.
- 2022-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $50.06K.
- 2021-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $61.27K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2022-09-30 | $73.02K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $67.44K 10-Q · filed 2022-10-28 |
| 2022-03-31 | $50.06K 10-Q · filed 2022-10-21 |
| 2021-12-31 | $61.27K 10-Q · filed 2022-11-14 |
| 2021-09-30 | $72.20K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $4.96M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $4.96M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $4.97M 10-Q · filed 2021-08-16 |
| 2020-12-30 | $0.00 10-Q · filed 2021-11-15 |
| 2020-09-30 | $4.97M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $5.00M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $4.99M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $5.04M 10-K · filed 2021-03-22 |
| 2019-09-30 | $5.03M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $5.05M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $5.06M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $5.07M 10-K · filed 2020-04-15 |
| 2018-09-30 | $5.09M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $5.13M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $5.18M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $5.21M 10-K · filed 2019-03-07 |
| 2017-09-30 | $5.24M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $5.26M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $5.32M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $5.32M 10-K · filed 2018-03-06 |
| 2016-09-30 | $5.33M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $5.32M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $5.18M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $5.15M 10-K · filed 2017-02-22 |
| 2015-09-30 | $3.90M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $4.05M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $4.05M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $3.39M 10-K · filed 2016-02-23 |
| 2014-09-30 | $13.67M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $12.84M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $10.69M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $11.10M 10-K · filed 2015-02-27 |
| 2013-09-30 | $11.60M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $12.10M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $13.06M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $14.15M 10-K · filed 2014-03-17 |
| 2012-09-30 | $15.00M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $16.18M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $12.49M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $13.18M 10-K · filed 2013-03-18 |
| 2011-09-30 | $4.67M 10-Q/A · filed 2011-11-14 |
| 2011-06-30 | $4.93M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $3.20M 10-K · filed 2012-03-13 |